PreComb Therapeutics

PreComb Therapeutics provides an automated high-throughput platform that generates 3D microtumours from patient-derived samples to predict drug responses across various doses and combinations. The technology, known as 3DTwin, uses longitudinal functional profiling to capture response and resistance dynamics over time. The company serves oncology drug development teams by supporting candidate prioritisation, indication expansion, and rational combination design.